Sociedad Española de Terapia Génica y Celular
  • Home
  • About us
    • About us
    • History
    • Board Information
    • Awards
      • Award winners
    • Legal & bylaws
  • Events
    • Events
    • Sponsorship
    • Ask-the-expert
    • Current congress
    • e-School
    • e-Seminars
    • Previous Events
    • Upcoming events
    • Frequently asked questions
  • Networking & community
    • Networking & community
    • Gene and cell therapy community heatmap
    • Introduction to the Forum
    • Latest news
    • Non ESGCT events
    • Jobs & Courses
    • Blog
    • Newsletter archive
    • National Gene and cell therapy societies
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
  • Public & Patients
    • Public & Patients
    • Gene and cell therapy education
      • Covid 19 vaccines
      • Gene therapy 101
        • Cell therapy basics
        • Different approaches
        • Gene therapy basics
        • Vectors 101
    • Patients perspective
    • Sites of interest
    • What is gene therapy
  • Membership
    • Membership
    • Become a member
    • General Assembly of Members
    • Human Gene Therapy
    • Membership benefits
Home

This week in gene and cell therapy - 16 November 2018

Gene and cell therapy headlines 12 - 16 November


MeiraGTx planning to launch trial of NIH developed gene therapy for Sjögren's syndrome

“significant improvements in liver biochemistry tests” in Gilead trial of gene therapy for liver condition

Encouraging results for NK cell cancer therapy in pre-clinical (Nkarta Therapeutics) and clinical studies (Fate Therapeutics)

DNAtrix and Valo Therapeutics (based on technology from Board Member Vincenzo Cerullo) announce a collaboration to develop enhanced onclytic viruses

UniQure achieves higher levels of factor IX in modified trial of gene therapy for haemophilia and prepares for phase 3

Gene therapy improves heart failure in mouse model

Celgene and Dragonfly Therapeutics announce partnership to develop NK cell therapies




 

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2022 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us